Literature DB >> 23250982

Sympathetic neural and hemodynamic responses to upright tilt in patients with pulsatile and nonpulsatile left ventricular assist devices.

David W Markham1, Qi Fu, M Dean Palmer, Mark H Drazner, Dan M Meyer, Brian T Bethea, Jeffrey L Hastings, Naoki Fujimoto, Shigeki Shibata, Benjamin D Levine.   

Abstract

BACKGROUND: Left ventricular assist devices (LVADs) are now widely accepted as an option for patients with advanced heart failure. First-generation devices were pulsatile, but they had poor longevity and durability. Newer generation devices are nonpulsatile and more durable, but remain associated with an increased risk of stroke and hypertension. Moreover, little is understood about the physiological effects of the chronic absence of pulsatile flow in humans. METHODS AND
RESULTS: We evaluated patients with pulsatile (n=6) and nonpulsatile (n=11) LVADs and healthy controls (n=9) during head-up tilt while measuring hemodynamics and muscle sympathetic nerve activity. Patients with nonpulsatile devices had markedly elevated supine and upright muscle sympathetic nerve activity (mean±SD, 43±15 supine and 60±21 bursts/min at 60° head-up tilt) compared with patients with pulsatile devices (24±7 and 35±8 bursts/min; P<0.01) and controls (11±6 and 31±6 bursts/min; P<0.01); however, muscle sympathetic nerve activity was not different between patients with pulsatile flow and controls (P=0.34). Heart rate, mean arterial pressure, and total peripheral resistance were greater, whereas cardiac output was smaller, in LVAD patients compared with controls in both supine and upright postures. However, these hemodynamic variables were not significantly different between patients with pulsatile and nonpulsatile flow.
CONCLUSIONS: Heart failure patients with continuous, nonpulsatile LVADs have marked sympathetic activation, which is likely due, at least in part, to baroreceptor unloading. We speculate that such chronic sympathetic activation may contribute to, or worsen end-organ diseases, and reduce the possibility of ventricular recovery. Strategies to provide some degree of arterial pulsatility, even in continuous flow LVADs may be necessary to achieve optimal outcomes in these patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23250982     DOI: 10.1161/CIRCHEARTFAILURE.112.969873

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  25 in total

1.  Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous-Flow Left Ventricular Assist Device: The Role of Pulsatility.

Authors:  Melissa A H Witman; Ryan S Garten; Jayson R Gifford; H Jonathan Groot; Joel D Trinity; Josef Stehlik; Jose N Nativi; Craig H Selzman; Stavros G Drakos; Russell S Richardson
Journal:  JACC Heart Fail       Date:  2015-08-12       Impact factor: 12.035

2.  CrossTalk opposing view: Blood flow pulsatility in left ventricular assist device patients is not essential to maintain normal brain physiology.

Authors:  William K Cornwell; Takashi Tarumi; Justin Lawley; Amrut V Ambardekar
Journal:  J Physiol       Date:  2018-12-17       Impact factor: 5.182

Review 3.  The baroreceptor as a therapeutic target for heart failure.

Authors:  Edoardo Gronda; Eric G Lovett; Michela Tarascio; Dimitrios Georgakopoulos; Guido Grassi; Emilio Vanoli
Journal:  J Cardiovasc Transl Res       Date:  2014-02-22       Impact factor: 4.132

4.  Changing pulsatility by delaying the rotational speed phasing of a rotary left ventricular assist device.

Authors:  Kazuma Date; Takashi Nishimura; Mamoru Arakawa; Yoshiaki Takewa; Satoru Kishimoto; Akihide Umeki; Masahiko Ando; Toshihide Mizuno; Tomonori Tsukiya; Minoru Ono; Eisuke Tatsumi
Journal:  J Artif Organs       Date:  2016-07-19       Impact factor: 1.731

5.  Continuous-flow mechanical circulatory support is not associated with early graft failure: An analysis of the International Society for Heart and Lung Transplantation registry.

Authors:  Kevin J Clerkin; Donna M Mancini; Josef Stehlik; Wida S Cherikh; Lars H Lund
Journal:  Clin Transplant       Date:  2019-11-26       Impact factor: 2.863

Review 6.  Left ventricular assist device-induced reverse remodeling: it's not just about myocardial recovery.

Authors:  Karolina K Marinescu; Nir Uriel; Douglas L Mann; Daniel Burkhoff
Journal:  Expert Rev Med Devices       Date:  2016-12-22       Impact factor: 3.166

Review 7.  The sympathetic nervous system and heart failure.

Authors:  David Y Zhang; Allen S Anderson
Journal:  Cardiol Clin       Date:  2014-02       Impact factor: 2.213

8.  Living Without a Pulse: The Vascular Implications of Continuous-Flow Left Ventricular Assist Devices.

Authors:  Suneet N Purohit; William K Cornwell; Jay D Pal; JoAnn Lindenfeld; Amrut V Ambardekar
Journal:  Circ Heart Fail       Date:  2018-06       Impact factor: 8.790

Review 9.  Chronic outpatient management of patients with a left ventricular assist device.

Authors:  Elisa M Smith; Jennifer Franzwa
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

Review 10.  Hypertension: an unstudied potential risk factor for adverse outcomes during continuous flow ventricular assist device support.

Authors:  Lauren T Wasson; Melana Yuzefpolskaya; Michiyori Wakabayashi; Hiroo Takayama; Yoshifumi Naka; Nir Uriel; Ulrich P Jorde; Ryan T Demmer; Paolo C Colombo
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.